Vicia faba L. Pod Valves: A By-Product with High Potential as an Adjuvant in the Treatment of Parkinson’s Disease
Molecules · 21.08.2024 · 29 (16) · 3943
DOI: 10.3390/molecules29163943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 21.08.2024. Verfasst von Carmen Tesoro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sciences, University of Basilicata, 85100 Potenza, Italy. Hauptthemen laut MEDLINE: Vicia faba, Parkinson Disease, Plant Extracts, Seeds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vicia faba L. is a leguminous plant with seeds rich in nutritional compounds, such as polyphenols and L-dopa, a dopamine precursor and first-line treatment for Parkinson’s symptoms. Recently, its by-products have been revalued as a sustainable source of bioactive compounds. In this study, aqueous extracts of Lucan broad bean pod valves (BPs) were characterized to evaluate their potential use as adjuvants in severe Parkinson’s disease. L-dopa content, quantified by LC-UV, was much higher in BPs than in seeds (28.65 mg/g dw compared to 0.76 mg/g dw). In addition, vicine and convicine, the metabolites responsible for favism, were not detected in pods. LC-ESI/LTQ-Orbitrap/MS2 allowed the identification of the major polyphenolic compounds, including quercetin and catechin equivalents, that could ensure neuroprotection in Parkinson’s disease. ESI(±)-FT-ICR MS was used to build 2D van Krevelen diagrams; polyphenolic compounds and carbohydrates were the most representative classes. The neuroprotective activity of the extracts after MPP+-induced neurotoxicity in SH-SY5Y cells was also investigated. BP extracts were more effective than synthetic L-dopa, even at concentrations up to 100 µg/mL, due to the occurrence of antioxidants able to prevent oxidative stress. The stability and antioxidant component of the extracts were then emphasized by using naturally acidic solutions of Punica granatum L., Ribes rubrum L., and gooseberry (Phyllanthus emblica L.) as extraction solvents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Sciences, University of Basilicata, 85100 Potenza, Italy.
- Endocannabinoid Research Group, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), 80078 Pozzuoli, Italy.
- Department of Chemistry and Biology, University of the Study of Salerno, 84084 Fisciano, Italy.
- Department of Pharmacy, University of the Study of Salerno, 84084 Fisciano, Italy.
- Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", University of Milan, 20133 Milan, Italy.
ORCID-Profile: Filomena Lelario, Fabiana Piscitelli, Angela Di Capua, Paolo Della Sala, Paola Montoro, Giuliana Bianco, Maria Assunta Acquavia, Mario Dell'Agli, Stefano Piazza, Rosanna Ciriello
Zitieren
APA
Tesoro, C., Lelario, F., Piscitelli, F., Di Capua, A., Della Sala, P., Montoro, P., Bianco, G., Acquavia, M. A., Dell'Agli, M., Piazza, S., & Ciriello, R. (2024). Vicia faba L. Pod Valves: A By-Product with High Potential as an Adjuvant in the Treatment of Parkinson’s Disease. Molecules, 29(16), 3943. https://doi.org/10.3390/molecules29163943
Vancouver
Tesoro C, Lelario F, Piscitelli F, Di Capua A, Della Sala P, Montoro P, et al. Vicia faba L. Pod Valves: A By-Product with High Potential as an Adjuvant in the Treatment of Parkinson’s Disease. Molecules. 2024;29(16):3943. doi:10.3390/molecules29163943
BibTeX
@article{Tesoro2024,
author = {Tesoro, Carmen and Lelario, Filomena and Piscitelli, Fabiana and Di Capua, Angela and Della Sala, Paolo and Montoro, Paola and Bianco, Giuliana and Acquavia, Maria Assunta and Dell'Agli, Mario and Piazza, Stefano and Ciriello, Rosanna},
title = {Vicia faba L. Pod Valves: A By-Product with High Potential as an Adjuvant in the Treatment of Parkinson’s Disease},
journal = {Molecules},
year = {2024},
volume = {29},
number = {16},
pages = {3943},
doi = {10.3390/molecules29163943}
}
EUVIMED